FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

443087004: Saxagliptin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2010. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2834307019 Saxagliptin (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2840308015 Saxagliptin en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Saxagliptin Is a Substance with dipeptidyl peptidase IV inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Saxagliptin Is a Oral hypoglycemic false Inferred relationship Existential restriction modifier
Saxagliptin Has disposition Dipeptidyl peptidase IV inhibitor true Inferred relationship Existential restriction modifier
Saxagliptin Is a Chemical categorized functionally false Inferred relationship Existential restriction modifier
Saxagliptin Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Saxagliptin Is a Substance with alcohol structure true Inferred relationship Existential restriction modifier
Saxagliptin Is a Nitrile true Inferred relationship Existential restriction modifier
Saxagliptin Is a Drug or medicament true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Saxagliptin + Dapagliflozin Has active ingredient True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets Has active ingredient True Saxagliptin Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) Has active ingredient True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 5mg tablets 28 tablet Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has basis of strength substance False Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Sigma Pharmaceuticals Plc) Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Sigma Pharmaceuticals Plc) 28 tablet Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Product containing precisely saxagliptin 2.5 milligram/1 each conventional release oral tablet Has basis of strength substance False Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg tablets 28 tablet Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Waymade Healthcare Plc) Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 5mg tablets (Waymade Healthcare Plc) 28 tablet Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 1g tablets Has basis of strength substance False Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 850mg tablets Has basis of strength substance False Saxagliptin Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 1g tablets 56 tablet Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 2.5mg / Metformin 850mg tablets 56 tablet Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/1000mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Waymade Healthcare Plc) Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Onglyza 2.5mg tablets (Waymade Healthcare Plc) 28 tablet Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets Has basis of strength substance False Saxagliptin Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Has basis of strength substance True Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin + Metformin Has active ingredient False Saxagliptin Inferred relationship Existential restriction modifier
Saxagliptin + Metformin Has active ingredient False Saxagliptin Inferred relationship Existential restriction modifier

Start Page 2 of 2

This concept is not in any reference sets

Back to Start